Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients
Conclusions: MS patients taking oral fingolimod treatment may be at risk for side‑effects caused by low Plt levels. This may not be a factor for patients with higher or normal Plt levels. However,a patient with naturally low Plt levels may experience a drop below the normal level and be at risk for excessive bleeding. In addition to these possible harmful side‑effects, the decreased Pltpopulation may pose positive effects for MS patients.Keywords: Fingolimod, multiple sclerosis, platelet
Source: International Journal of Preventive Medicine - Category: Global & Universal Source Type: research